<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29267616</article-id><article-id pub-id-type="pmc">5731303</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2016-0064</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Neuroprotective Anesthesia Regimen and Intensive Management for
Pediatric Cardiac Surgery with Cardiopulmonary Bypass: a Review and Initial
Experience</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Klamt</surname><given-names>Jyrson Guilherme</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Vicente</surname><given-names>Walter Villela de Andrade</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Garcia</surname><given-names>Luis Vicente</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Carmona</surname><given-names>Fabio</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Abr&#x000e3;o</surname><given-names>Jo&#x000e3;o</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Menardi</surname><given-names>Ant&#x000f4;nio Carlos</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Manso</surname><given-names>Paulo Henrique</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1">
<label>1</label> Hospital das Clinicas da Faculdade de Medicina de
Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo (FMRP-USP),
Ribeir&#x000e3;o Preto, SP, Brazil.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Jyrson Guilherme Klamt, Faculdade de
Medicina de Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo,
Department of Biomechanics Medicine and Rehabilitation, Av. Bandeirantes, 3900 -
Ribeir&#x000e3;o Preto, SP, Brazil - Zip code: 14098-558. E-mail:
<email>jgklamt@fmrp.usp.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Oct-Dec</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2017</year></pub-date><volume>32</volume><issue>6</issue><fpage>523</fpage><lpage>529</lpage><history><date date-type="received"><day>04</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>This article describes our proposal for routine anesthesia, intraoperative
medical management, cerebral and physiological monitoring during pediatric
cardiac surgery with cardiopulmonary bypass that intend to provide appropriate
anesthesia (analgesia, hypnosis), neuroprotection, adequate cerebral and
systemic oxygen supply, and preventing against drugs neurotoxicity. A concise
retrospective data is presented.</p></abstract><kwd-group><kwd>Pediatrics</kwd><kwd>Cardiac Surgical Procedures</kwd><kwd>Neuroprotection</kwd><kwd>Cardiopulmonary Bypass</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AEP</td><td align="left" rowspan="1" colspan="1">= Auditory evoked potentials</td></tr><tr><td align="left" rowspan="1" colspan="1">BIS</td><td align="left" rowspan="1" colspan="1">= Bispectral index</td></tr><tr><td align="left" rowspan="1" colspan="1">CBF</td><td align="left" rowspan="1" colspan="1">= Cerebral blood flow</td></tr><tr><td align="left" rowspan="1" colspan="1">CMRO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">= Cerebral metabolic rate of oxygen</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1">= Computed tomography</td></tr><tr><td align="left" rowspan="1" colspan="1">EEG</td><td align="left" rowspan="1" colspan="1">= Electroencephalogram</td></tr><tr><td align="left" rowspan="1" colspan="1">MRI</td><td align="left" rowspan="1" colspan="1">= Magnetic resonance image</td></tr><tr><td align="left" rowspan="1" colspan="1">NIRS</td><td align="left" rowspan="1" colspan="1">= Near-infrared spectroscopy technology</td></tr><tr><td align="left" rowspan="1" colspan="1">NSE</td><td align="left" rowspan="1" colspan="1">= Neuron specific enolase</td></tr><tr><td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">= Arterial partial pressure of carbon dioxide</td></tr><tr><td align="left" rowspan="1" colspan="1">rScO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">= Cerebral regional oximetry</td></tr><tr><td align="left" rowspan="1" colspan="1">SaO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">= Arterial hemoglobin oxygen saturation</td></tr><tr><td align="left" rowspan="1" colspan="1">SjO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">= Jugular hemoglobin oxygen saturation</td></tr><tr><td align="left" rowspan="1" colspan="1">SsvcO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">= Superior vena cava hemoglobin oxygen saturation</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Perioperative neurologic monitoring of small children has become routine in most
major centers and the pertaining data suggest that the technologies identify adverse
neurologic events and may indeed predict outcome. Monitoring methods currently used
included processed electroencephalography (BIS- bispectral index), cerebral oximetry
(NIRS- near-infrared spectroscopy) and Doppler ultrasound. On the other hand,
neuroprotective therapies (drugs and procedures) are still controversy and used
empirically.</p><p>Pediatric cardiac surgery survival rate, which is more than 95% in highly developed
institutions, and the incidence of severe neurological sequel have been dramatically
improved over time, so that attention has been focused on long term functional
morbidity, especially neurodevelopmental disabilities. Unfortunately, neurological
injury still occurs in children as a consequence of heart surgery with
cardiopulmonary bypass (CPB). In large USA centers, 40-50% of children aged 4-5
years who were submitted to complex heart surgeries during the neonatal period or
before six months of age present delayed neurocognitive development, including
cognitive, motor and emotional deficit, delayed fine motor skills, language, speech
and motor visual organization, as well as attention deficit and
hyperactivity<sup>[<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Recently, in neonates undergoing
cardiac surgery with CPB, who were monitored with cerebral oximetry
(rScO<sub>2</sub>) with near-infrared spectroscopy technology (NIRS) and
cerebral blood flow (CBF) with Doppler ultrasound, the swift treatment of
ischemia-hypoxia detected events resulted in better neurodevelopmental outcomes
accessed by Bayle Scale III for language and motor performance<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>Severe neurological sequeale (coma, cerebral palsy, choreoathetosis, epilepsy, and
hemiparesis) are much less frequent (occurring in less than 10% of cases). The
actual incidence of deficits is difficult to define and may only be evident several
years after cardiac operation due to the limitations of functional evaluation of
neonates and infants and to the potential changes produced by neuroplasticity.
Because of the lifelong personal expenses and efforts associated with neurological
sequels, timely investments in prevention and treatment are socially and
individually justified. The major costs of prolonged intensive therapies in cases of
serious neurological sequels should also be considered<sup>[<xref rid="r4" ref-type="bibr">4</xref>-<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>Real-time neurologic and cardiorespiratory monitoring should be an integral part of
neuroprotective strategies for pediatric patients requiring cardiac surgery. It also
allows appropriate and swift management to detect and counteract decrease in
cerebral oxygenation. Ideally, real-time monitoring should allow easy, reliable, and
reproducible detection of adverse outcome events and their causes.</p></sec><sec><title>MECHANISMS OF NEUROLOGICAL INJURY DURING HEART SURGERY</title><p>The etiology of brain damage is multifactorial regarding the time and mechanism of
injury. One must consider that preoperative abnormalities (hyper/hypotonia,
difficulty in feeding, choreoathetosis, spasticity, macro/microcephaly) are
identified in 50% of neonates with congenital heart disease and are predictive
factors of neurodevelopmental disability after heart surgery<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Magnetic resonance image (MRI) and
computed tomography (CT) have demonstrated a 10-30% incidence in brain abnormalities
such as metabolic dysfunction, structural anomalies and white matter damage
(leukomalacia) in children with congenital heart disease. Leukomalacia has been
identified in 50% of children submitted to heart surgery and is associated with
diastolic hypotension and hypoxemia<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>The mechanisms of postoperative brain damage are still controversial, although
hypoxemia, global ischemia and post ischemic reperfusion damage appear to be the
major components. Other mechanisms include embolism, anesthetic neurotoxicity,
inflammatory responses and modification of cell life-cycle development (apoptosis).
The neurological damage of ischemia-hypoxia results from an inadequate oxygen and
glucose supply needed to guarantee the energy requirements for the neurons, glia,
endothelium, and support tissues that form the neurovascular unit<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The initial events of the
ischemic-hypoxic process include excitotoxicity, intracellular calcium overload,
energy failure (ATP depletion), oxidative and nitrosoactive stress that result in
cell death (necrosis) in the infarction nucleus. Late events such as an inflammatory
process and apoptosis (programmed death) are relevant regarding neuronal death in
the penumbra tissue ischemia. All together, these phenomena are known as continuous
necrosis-apoptosis of neonatal brain injury<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. The degree of ischemia of the infarction nucleus is the
primary risk factor that distinguishes ischemic damage from the penumbra region, as
determined on animal models that evaluated the degree of hypoxia and cerebral blood
flow<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p><p>The reduction of neurological sequels by the handling of manageable risk factors is
based on the interruption of the cerebral ischemia-hypoxia process as soon as it
arises (within minutes of its occurrence) or by providing timely intervention while
a therapeutic window still exists. This approach has received priority attention on
the part of pediatricians, surgeons, and anesthesiologists. Manageable and
modifiable intraoperative period factors include hematocrit during CPB, acid-base
management, regional cerebral perfusion, cooling and rewarming during CPB rates,
high cerebral vascular resistance, alteration in cerebral autoregulation (BP-
rScO<sub>2</sub> relationship) during deep hypothermia, glycemia, mean and
diastolic BP, pulmonary vascular resistance, seizures, PaCO<sub>2</sub>, and cardiac
output<sup>[<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Brain oxygenation monitoring with NIRS or
SsvcO<sub>2</sub> (superior vena cava hemoglobin oxygen saturation), largely
determined by cerebral venous flow, and real time functional integrity
(electroencephalogram (EEG), evoked potentials) monitoring in real time are of
primordial importance, and avoid or minimize the use of anesthetic associated with
neurotoxicity (apoptosis) such as volatile anesthetics and ketamine should be part
of advocated anesthesia cardiac pediatric surgery protocols<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Critical periods of cerebral
oxygenation reduction typically occur during the induction of anesthesia when
hypotension and decrease of cardiac output take place, cannulation for CPB, low-flow
or variable flow during CPB, rewarming and separation from CPB<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p></sec><sec><title>EVALUATIONS OF BRAIN INJURY</title><p>The application of specific neurological monitoring for the detection of cerebral
ischemia/hypoxia such as continuous brain oxygenation by the NIRS technique and
transcranial Doppler or for immediate neurophysiological repercussions of
neurological injury, processed EEG techniques such as BIS and evoked potentials may
lead to rapid therapeutic intervention as well as refinement of risk reduction
strategies. Prospective cohort study has shown that neurophysiological monitoring
may afford a sound bases for rapid therapeutic intervention resulting in reduction
of this complication from 26 to 6%<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>On the other hand, biochemical markers, neural band creatine kinase (CK-BB), neuron
specific enolase (NSE) and S100&#x003b2; protein are also of great theoretical
importance<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> however,
unfortunately, their determination still requires a too long time before a
neuroprotective therapy can be started, in contrast to NIRS and functional
neurophysiological evaluations can be performed in real time.</p><p>The growing attention devoted to the brain functioning development in children,
particularly neonates, has been emphasizing the usefulness of neurological
monitoring of cerebral hypoxia, blood perfusion anomalies and electrophysiological
disorders acknowledge as a surrogate for neurologic injury events (seizures, delta
pattern of the EEG)<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. The most
frequent employed brain monitors (neuromonitors) include NIRS (which measures
regional oxygen saturation - rSO<sub>2</sub>), processed EEG and transcranial
Doppler (which estimate cerebral blood flow-CBF). These monitors devices with other
standard physiological monitoring techniques increase our ability to detect and
prevent damage resulting from ischemia-hypoxemia, embolism, hypocapnia, arterial
hypotension, low cardiac output, and hyperthermia during surgery and over
postoperative intensive therapy. Functional tests of specific neural systems are
seldom used as auditory evoked potentials (AEP) and somatosensory evoked potentials
to assess the synaptic integrity of the neural pathways. Continuous measurements of
arterial hemoglobin oxygen saturation (SaO<sub>2</sub>), systemic arterial pressure
and central venous oxygen saturation (SvO<sub>2</sub>) do not predict in an adequate
manner brain desaturation<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>. For this reason, continuous
monitoring by cerebral NIRS is being adopted as a universal strategy (for all
patients) for the detection of cerebral desaturation events that may occur in
unpredictable manner, but that respond normally to therapeutic
intervention<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.
Notwithstanding, the simultaneous measurement of cerebral and somatic
rSO<sub>2</sub> may provide a body map of cardiac output distribution, low
cardiac output and/or specific low cerebral blood flow<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p></sec><sec><title>MEASUREMENT OF CEREBRAL OXYGENATION</title><p>The most frequently employed technique is the determination of SjO<sub>2</sub> and
rSO<sub>2</sub> by NIRS, representing global (hemispheric) and regional
oxygenation, respectively. The two variables are highly correlated and the
tendencies are monitored<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, both
describing the relation between cerebral metabolic rate of oxygen (CMRO<sub>2</sub>)
and oxygen supply. The NIRS has the advantage of not being invasive, of being a
dynamic marker in real time, without requiring pulsatile method such as pulse
oximetry, and being useful during CPB with hypothermia and during resuscitation
after a cardiac arrest. The cerebral NIRS provides a reliable measure of venous
saturation below the sensors, especially in small skulls such as those of
neonates<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. The cerebral
regional oximetry (rScO<sub>2</sub>) is strongly correlated with neurological
evolution in experiments of cerebral ischemia-hypoxia. In piglets submitted to
progressive degrees of hypoxia, NIRS was strongly correlated with neurocognitive
dysfunction and cerebral blood flow. Increased lactate production (measure of
anaerobic metabolism), low frequency (&#x0003c;4 Hz) in the electrocardiogram, and energy
failure (ATP depletion) occur when rSO<sub>2</sub> fell to 44%, 42% and 33%,
respectively. Changes in CBF are also correlated with cerebral rSO<sub>2</sub> and
with biochemical and electrophysiological markers. A 58% reduction of CBF marks the
threshold for the installation of ischemia-hypoxia injury associated with a cerebral
rSO<sub>2</sub> of less than 50%<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. During CPB, the period of rewarming carries the greatest risk
for cerebral hypoxia regardless of appropriate SaO<sub>2</sub><sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p></sec><sec><title>FUNCTIONAL MEASUREMENTS OF BRAIN INJURY</title><p>The EEG during the per operatory period of pediatric heart surgery permits the
detection of neocortical synaptic activities. The EEG pattern, in addition to
cerebral perfusion, is influenced by the cerebral temperature, alert state,
anesthetic drugs, and age. The interpretation of the EEG is operator-dependent and
the signals may suffer electric interferences; however, the signals can be processed
with various algorithms to reduce their complexity and the interpretation task.
Fourier analysis of the EEG generates a series of numerical descriptors including
spectral edge frequency, total potency and suppression ratio that may have a poorly
consistent relationship with cerebral ischemia. The BIS quantitates the cortical
activity by spatial non-coherence and has a probabilistic relation with the depth of
anesthesia and the degree of sedation; however, it suffers the influence of various
drugs and of temperature and of the supply of oxygen and glucose to the brain. At
profound hypothermia, a body temperature of less than 28&#x000ba; C, the electrical activity
may be processed to the isoelectric point, which may not be distinguished from
profound anesthesia<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. The
relationship between cerebral perfusion and EEG abnormalities, although poorly
consistent and nonlinear, may provide a clinically useful marker of cerebral
ischemia (EEG frequency &#x0003c; 4 Hz, convulsive activities)<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. However, when it is detected, the ischemic
injury should have already occurred. Importantly, combined NIRS and EEG monitoring
reduces the incidence of brain damage observed by magnetic resonance (an early
marker)<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>On CPB, when usual clinical signs of anesthesia are not available, processed EEG
technology monitoring, such as BIS, are advantageous anesthetic depth determination.
BIS monitoring compute a number that range from zero (isoelectric) to the mean awake
values in 90-100 range in adults, children and infants. BIS values are reported to
decrease during hypothermia and anesthetic dose required to achieve BIS values of
40-60 (deep hypnosis levels) are decreased during hypothermia. During rewarming
phase of hypothermia CPB in children, BIS is reported to increase, perhaps
reflecting an actual increase of conscious levels. BIS monitoring is reported to
help the detection central nervous system hypoperfusion and cerebral embolism. It
has been combined with NIRS to detect cerebral ischemia during cardiac surgery in
children<sup>[<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>. During adult cardiac surgery,
anesthesia controlled by BIS monitoring may facilitate titration of anesthetic
agents, and decrease the hemodynamics disturbances. Inversely, fewer intraoperative
hemodynamics events occur with BIS monitoring<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. Additionally, BIS can predict bad neurological outcome in
comatose survivors after cardiac arrest and induced hypothermia<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</p><p>Nowadays, NIRS is the most frequently used brain monitor due to practical reasons.
The use of various continuous monitoring modalities such as regional oximetry (NIRS)
and processed EEG (BIS), Doppler ultrasound are complementary rather than exclusive.
Application of combination of these monitors might be the best current approach.
Indeed, several authors have developed prevention measures and treatments algorithms
based on multimodal neurological monitoring. However, evoked potentials, such as
AEP, can be an additional tool to provide additional neurophysiological information
regarding the functional integrity of the neuronal pathway on real time<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p></sec><sec><title>NEUROPROTECTIVE ANESTHESIA AND INTRAOPERATIVE IN-TENSIVE MEDICAL CARE</title><p>Neuroprotective strategies can be classified as preventive, reactive and reparative.
Anesthesia and hypothermia are most involved with preventive therapeutics strategies
since it is given in advance of the anticipated cerebral insult such as circulatory
arrest, cumulating of periods of low-flow CPB, hypotension, cerebral hyperthermia
and vasoconstriction during rewarming on CPB<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Reaction strategies requires cerebral oxygenation
monitoring with NIRS or SsvcO<sub>2</sub>, combined with hemodynamic, arterial
oxygenation, core body temperature and metabolic (PaCO<sub>2</sub>, glycemia,
lactate) monitoring. Neurophysiological monitoring such as processed EEG (BIS) and
AEP, and cerebral blood flow measurement with Doppler can be complementary and
improve the fast detection and management of cerebral hypoxia.</p><p>Erythropoietin is the only available drug that has scientific rationale and
pre-clinical data for two phases of neuroprotective strategies (preventive and
reparative) and had safety and efficacy studies (Phase I/II) in neonate<sup>[<xref rid="r26" ref-type="bibr">26</xref>,<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Nevertheless, despite of its extreme safety in neonate,
future studies concerning its efficacy in cardiac surgery with CPB are required.
Besides volatile anesthetics (sevoflurane, isoflurane), intravenous anesthetics
GABAA agonist (propofol, midazolan) and NMDA antagonist (ketamine), that are
routinely used during cardiac pediatric anesthesia as a complement of the high
induction of opioid anesthesia, other adjuvant drugs can also be used because of
their hypnotic, analgesic, vasodilator (sympatholytic effect), antiarrhythmic,
anti-inflammatory effects and anticonvulsant effects. Among them,
dexmedetomidine<sup>[<xref rid="r28" ref-type="bibr">28</xref>-<xref rid="r32" ref-type="bibr">32</xref>]</sup>, magnesium sulfate<sup>[<xref rid="r33" ref-type="bibr">33</xref>-<xref rid="r35" ref-type="bibr">35</xref>]</sup>, lidocaine<sup>[<xref rid="r36" ref-type="bibr">36</xref>-<xref rid="r38" ref-type="bibr">38</xref>]</sup>,
chlorpromazine<sup>[<xref rid="r39" ref-type="bibr">39</xref>]</sup>,
although presenting neuroprotective properties in animal model of ischemia/hypoxia,
suffer from conflicting clinical evidence for their putative benefits. The clinical
evidence for their benefits are still conflicting<sup>[<xref rid="r40" ref-type="bibr">40</xref>-<xref rid="r42" ref-type="bibr">42</xref>]</sup>.
Dexmedetomidine has been used in combination with opioid in order to provide
hypnosis and deep intraoperative analgesia during pediatric cardiac
surgery<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> and it is
considered a therapeutic agent against ventricular and supraventricular
tachyarrhythmias<sup>[<xref rid="r43" ref-type="bibr">43</xref>]</sup>.
Chlorpromazine is an effective systemic vasodilator in neonate on CPB<sup>[<xref rid="r44" ref-type="bibr">44</xref>]</sup>. Interestingly, spontaneous
moderate hypothermia (33-34&#x000b0;C) and permissive hypercapnia may contribute to organ
protection during pediatric cardiac surgery with CPB<sup>[<xref rid="r44" ref-type="bibr">44</xref>,<xref rid="r45" ref-type="bibr">45</xref>]</sup>. The
combination of dexmedetomidine, magnesium sulfate, lidocaine infusion and ketamine,
called opioid-free anesthesia, is an acceptable, safe and effective anesthesia
techniques in adult patients<sup>[<xref rid="r46" ref-type="bibr">46</xref>]</sup>.</p><p>Despite of intensive research on the field of neuroprotection with drugs and
procedures (moderate hypothermia, remote preconditioning), the development of
reliable clinical neuroprotective therapy during pediatric cardiac surgery which
individually or in appropriate combination that can maintain blood pressure, cardiac
output, and cerebral oxygenation, block the transmembrane and large volume shift,
inflammatory, oxidative pathway, and the release of excitotoxic neurotransmitter
(glutamate) or block their postsynaptic effects that leads to neuronal death have
not been stablished yet. The advocated neuroprotective regimens have most of their
evidence based on animal basic studies and translated to clinical practice -
"bench-to-bedside approach". Proper animal's studies that reproduces the clinical
conditions and assessment, validation and pilot studies to prove the concept in
patients, particularly in neonate, followed by controlled studies are indicated.
Recent dating regarding neuroprotection strategies may be controversy because there
are multiple factors that contribute to brain injury and assessment of long-term
neurocognitive outcome is problematic<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r46" ref-type="bibr">46</xref>,<xref rid="r47" ref-type="bibr">47</xref>]</sup>.</p><p>Besides anesthetics and adjunct drugs above mentioned, other well accepted procedures
and physiological controls are routinely applied during cardiac surgery with CPB,
including mild to moderate hypothermia (core temperature of 33-34&#x000b0;C), deep
hypothermia (core temperature of 17-26&#x000b0;C), hematocrit over 24%, glycemia &#x0003e;100
mg%, pH management, prophylactic anti-inflammatory, selective cerebral perfusion,
ultrafiltration. A protocol for physiologic targets is established in order to
guarantee appropriate cerebral and systemic oxygen supply: 1- MABP (mean arterial
blood pressure) 40-50 and DBP (diastolic blood pressure) &#x0003e; 30 mmHg; 2-
SsvcO<sub>2</sub> or rScO<sub>2</sub> &#x0003e;65% and &#x0003e; 75% during CPB; 3-
arterial pulse profile visually normal; 4- mild hypothermia (33-34&#x000b0;C) before CPB and
normothermia (35-36&#x000b0;C) after CPB; 5- glycemia = 100 - 180 mg%; 6- Htc &#x0003e; 35% and
&#x0003e;25% (during CPB); 7- plasma calcium &#x0003e; 1.20 mmol/L; 8- plasma lactate &#x0003c; 2
mmol/L, 9- diuresis &#x02265; 1 ml/kg/h; 10- CVP = 6-10 mmHg, 11- SpO<sub>2</sub> =80
- 95%; 12- PaCO<sub>2</sub> = 35-55 mmHg; and 13- BIS = 45-70 in children over 6
months and core temperature over 30&#x000b0;C. These required end-points can almost always
be accomplished through management of hemodynamic (volume loading and vasoactive
drugs), ventilation patterns and FiO<sub>2</sub>, and anesthesia deepness through
opioid dosing and adjuvant drugs. Specific cerebral ischemia-hypoxia can occur with
low PaCO<sub>2</sub> (&#x0003c;30 mmHg), high core temperature (&#x0003e;38&#x002da;C), and light
anesthesia (pain, awareness). On the other hand, when cardiac output is critically
low, permissive hypercapnia can lead to splanchnic and renal ischemia<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>.</p><p>Sedation for transport and monitoring can be promoted by midazolan (50-100
&#x000b5;g/kg) plus ketamine (0.5-1 mg/kg) boluses. An anesthetic induction that
allows tracheal intubation, arterial and central venous cannulation can be carried
out with midazolam (0.1mg/kg), lidocaine (1.5 mg/kg), fentanyl (5 &#x000b5;g/kg), and
vecuronium (0.4 mg/kg). The anesthesia is maintained with fentanyl (50 &#x000b5;g/kg
before CPB and more 25-150 &#x000b5;g/kg until the end of surgery), lidocaine (1.5
mg/kg/h), and dexmedetomidine infusion (1 &#x000b5;g/kg/h) started soon after
arterial and central venous cannulation and physiologic and laboratorial monitoring.
Magnesium sulfate (50 mg/kg followed by 15 mg/kg/h) is administered at the beginning
of CPB. An infusion of norepinephrine (0.03-0.06 &#x000b5;g/kg/min) or boluses of
vasopressors phenylephrine or ephedrine should be given to minimize the blood
pressure and heart rate decrease caused by fentanyl, dexmedetomidine and magnesium
administration, particularly those hemodynamic unstable or in critical condition.
Recently, we changed the anesthetic technique by given continuous infusion of
dexmedetomidine, magnesium sulfate and lidocaine without bolus, to avoid decrease in
BP, HR and cardiac output (SvcsO<sub>2</sub> or rScO<sub>2</sub>&#x0003c; 60%).
Sevoflurane can be used for induction in children with no venous access and for
short-time control of hyper dynamic responses (increases in systolic arterial
pressure and heart rate above 30% of control levels). All the patients receive
dexchlorpheniramine (0.2 mg/kg), hydrocortisone (20 mg/kg) and ranitidine (2 mg/kg).
Chlorpromazine (0.5-5 mg/kg) is administered for arterial hypertension control. All
patients receive milrinone (0.5-0.7 &#x000b5;g/kg/min), when starting the rewarming
during CPB.</p><p>This anesthetic protocol is supported by basic studies and recent cohort that have
demonstrated that high doses of fentanyl and benzodiazepine are associated with
neuroprotection and less apoptosis, and higher cognitive scores and less new MRI
brain injury while exposure to volatile anesthetics and ketamine lower the cognitive
scores in neonate undergoing cardiac surgery<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. There are, also, a strong body of evidences that
dexmedetomidine can in fact be neuroprotective, anti-apoptotic, and antagonize the
behavioral impairment caused by inhaled anesthetics in neonate<sup>[<xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r29" ref-type="bibr">29</xref>]</sup>. The safety of general anesthetic in neonate has come
under contention after accumulating reports from preclinical studies revealed that
general anesthetic exposure leads to widespread apoptosis neurodegenerative and
long-lasting cognitive and learning impairment in immature and developing brain
(neonate). Animal studies and some clinical studies has shown the neurotoxicity of
prolonged (more than 3 hours) or repeated exposure to GABAA agents (inhaled
anesthetics, benzodiazepines, nitrous oxide, propofol, barbiturates) and NMDA
receptors antagonists (ketamine) produce cognitive and behavioral deficits such as
learning and memories deficits<sup>[<xref rid="r48" ref-type="bibr">48</xref>]</sup>. The ghost of the routinely anesthetic agents as a contributing
factor for neuronal apoptosis and consequent neurocognitive impairment in human
neonate remain a current concern. We believe that high induction dose of opioid
anesthesia associated with alpha<sub>2</sub> agonists (clonidine, dexmedetomidine)
is a better alternative to current volatile anesthesia technique in neonate. On the
other hand, the cardiovascular limitation of the developing heart to depressant
effects of general anesthetic due to its limited contractility, low compliance and
frequency dependency, significant hypotension and reduction of cardiac output
associated with anesthesia can cause decrease in cerebral blood flow and oxygenation
which can exaggerate drug neurotoxicity. Ketamine anesthesia induction can maintain
blood pressure and heart rate, and despite of potential neurotoxicity of prolonged
administration, a single dose of 0.5-1 mg/kg can, in fact, be
neuroprotective<sup>[<xref rid="r49" ref-type="bibr">49</xref>]</sup>. Also,
a short period of sevoflurane anesthesia to provide hypnosis and hemodynamic
control, should not cause neurologic harm<sup>[<xref rid="r50" ref-type="bibr">50</xref>]</sup>.</p><p>The present advocated neuroprotective anesthetic regimen was used in 52 pediatric
patients undergoing cardiac surgery with CPB. SsvcO<sub>2</sub>&#x0003e; 65% was
considered the end-point criteria for hemodynamic and respiratory management,
weaning from the CPB and to pediatric intensive care unit admission. In this
retrospective cohort, with pediatric patients aging from 1 day to 14 years weighting
2-28 kg, SsvcO<sub>2</sub> at the end of surgery varied from 67 to 87 %
(76&#x000b1;6). One patient died at the end of the surgery and one had low
SsvcO<sub>2</sub>&#x0003c;50% due to cardiac arrhythmia that improved after careful
adjustment of the pacemaker. The fentanyl dose range was 56 to 170 &#x000b5;g/kg.
Twenty-four percent of the patients received chlorpromazine (0.5-5 mg/kg), to
control systemic hypertension during and after CPB. All patients were transported to
PICU on milrinone (0.5-0.7 &#x000b5;g/kg/min) but less than 50% required
catecholamine at the end of surgery. Although the perioperative clinical results yet
observed seems very promising and warrant a clinical research trial to test organ
protection efficacy, we must avoid over-enthusiasm in adoption this anesthetic
technique for all patients with congenital heart disease undergoing undergoing
cardiac surgery with CPB, and we should maintain healthy skepticism until controlled
study are carried out.</p><p>Recently, we have been using a combined infusion of dexmedetomidine (1
&#x000b5;g/kg/h), magnesium sulfate (30 mg/kg/h), and lidocaine (2 mg/kg/h)
associated with fentanyl (&#x02265; 75 &#x000b5;g/kg). The infusion starts soon after
arterial cannulation and is halved after one hour. All patients are monitored with
cerebral and somatic (renal) regional oximetry and BIS (over 3 month of age).
Various degree of systemic vasodilation at the end of surgery is a common feature. A
protocol for study with a controlled, randomized, double-blind and stratified design
was started, comparing the proposal anesthetic neuroprotective regimen against the
standard anesthesia care with opioid-midazolan anesthesia. The primary outcome will
be cerebral/somatic oximetry with NIRS technology, neurophysiological and
biochemical organs injury markers, perfusion pressure and vasoactive drugs
requirement, inflammatory markers (protein C reactive and IL-6), ventilation
patterns FiO<sub>2</sub>, PEEP), organs perfusion pressures, oxygen extraction,
duration of mechanical ventilation and length of stay in pediatric intensive care
unit.</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">JGK</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">WVAV</td><td align="left" rowspan="1" colspan="1">Conception and design of the target clinical management
criteria, responsible surgeon, critical review and manuscript
drafting; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">LVG</td><td align="left" rowspan="1" colspan="1">Data acquisition and interpretation; final approval of
the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">FC</td><td align="left" rowspan="1" colspan="1">Design of the clinical target clinical managements,
data interpretation, postoperative care; final approval of the
version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">JA</td><td align="left" rowspan="1" colspan="1">Data acquisition and interpretation; final approval of
the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">ACM</td><td align="left" rowspan="1" colspan="1">Final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">PHM</td><td align="left" rowspan="1" colspan="1">Preoperative care, pediatric patient's selection, data
interpretation; final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Hospital das Clinicas da Faculdade de Medicina de
Ribeir&#x000e3;o Preto da Universidade de S&#x000e3;o Paulo (FMRP-USP),
Ribeir&#x000e3;o Preto, SP, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majnemer</surname><given-names>A</given-names></name><name><surname>Limperopoulos</surname><given-names>C</given-names></name><name><surname>Shevell</surname><given-names>M</given-names></name><name><surname>Rosenblatt</surname><given-names>B</given-names></name><name><surname>Rohlicek</surname><given-names>C</given-names></name><name><surname>Tchervenkov</surname><given-names>C</given-names></name></person-group><article-title>Long-term neuromotor outcome at school entry of infants with
congenital heart defects requiring open-heart surgery</article-title><source>J Pediatr</source><year>2006</year><volume>148</volume><issue>1</issue><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">16423601</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crighton</surname><given-names>DE</given-names></name><name><surname>Robertson</surname><given-names>CM</given-names></name><name><surname>Sauve</surname><given-names>RS</given-names></name><name><surname>Moddemann</surname><given-names>DM</given-names></name><name><surname>Alton</surname><given-names>GY</given-names></name><name><surname>Nettel-Aguirre</surname><given-names>A</given-names></name><etal/></person-group><article-title>Neurocognitive, functional, and health outcomes at 5 years of age
for children after complex cardiac surgery at 6 weeks of age or
younger</article-title><source>Pediatrics</source><year>2007</year><volume>120</volume><issue>3</issue><fpage>e478</fpage><lpage>e486</lpage><pub-id pub-id-type="pmid">17766491</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sood</surname><given-names>ED</given-names></name><name><surname>Benzaquen</surname><given-names>JS</given-names></name><name><surname>Davis</surname><given-names>PR</given-names></name><name><surname>Woodford</surname><given-names>E</given-names></name><name><surname>Pizzarro</surname><given-names>C</given-names></name></person-group><article-title>Predictive value of perioperative near-infrared spectroscopy for
neurodevelopmental outcomes after cardiac surgery in infancy</article-title><source>J Thorac Cardiovasc Surg</source><year>2013</year><volume>145</volume><issue>2</issue><fpage>438</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">23219333</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andropoulus</surname><given-names>DB</given-names></name><name><surname>Brady</surname><given-names>KM</given-names></name><name><surname>Easley</surname><given-names>RB</given-names></name><name><surname>Fraser Jr.</surname><given-names>CD</given-names></name></person-group><article-title>Neuroprotection in pediatric cardiac surgery: what is on the
horizon?</article-title><source>Prog Pediatr Cardiol</source><year>2010</year><volume>29</volume><issue>2</issue><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">20802846</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>GM</given-names></name><name><surname>Chanayen</surname><given-names>NS</given-names></name></person-group><article-title>Perioperative neuromonitoring in pediatric cardiac surgery:
techniques and targets</article-title><source>Prog Pediatr Cardiol</source><year>2010</year><volume>29</volume><fpage>123</fpage><lpage>130</lpage></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>GM</given-names></name></person-group><article-title>Neurologic monitoring on cardiopulmonary bypass: what are we
obligated to do?</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>81</volume><issue>8</issue><fpage>S2373</fpage><lpage>S2380</lpage><pub-id pub-id-type="pmid">16731106</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limperopoulos</surname><given-names>C</given-names></name><name><surname>Majnemer</surname><given-names>A</given-names></name><name><surname>Shevell</surname><given-names>MI</given-names></name><name><surname>Rosemblatt</surname><given-names>B</given-names></name><name><surname>Rohliceck</surname><given-names>C</given-names></name><name><surname>Tchervenkov</surname><given-names>C</given-names></name></person-group><article-title>Neurologic status of newborns with congenital heart defects
before open heart surgery</article-title><source>Pediatrics</source><year>1999</year><volume>103</volume><issue>2</issue><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">9925832</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuillen</surname><given-names>PS</given-names></name></person-group><article-title>Magnetic resonance imaging in congenital heart disease: what to
do with what we see and don't see?</article-title><source>Circulation</source><year>2009</year><volume>119</volume><issue>5</issue><fpage>660</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">19204316</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferriero</surname><given-names>DM</given-names></name></person-group><article-title>Neonatal brain injury</article-title><source>N Engl J Med</source><year>2004</year><volume>351</volume><issue>19</issue><fpage>1985</fpage><lpage>1995</lpage><pub-id pub-id-type="pmid">15525724</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>MD</given-names></name></person-group><article-title>Adventures in the pathophysiology of brain ischemia: penumbra,
gene expression, neuroprotection: the 2002 Thomas Will
Lecture</article-title><source>Stroke</source><year>2003</year><volume>34</volume><issue>1</issue><fpage>214</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">12511777</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>TE</given-names></name><name><surname>Wernovsky</surname><given-names>G</given-names></name><name><surname>Gaynor</surname><given-names>JW</given-names></name></person-group><article-title>Cause and prevention of central nervous system injury in neonates
undergoing cardiac surgery</article-title><source>Semin Thorac Cardiovasc Surg</source><year>2007</year><volume>19</volume><issue>3</issue><fpage>269</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">17983956</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuillen</surname><given-names>PS</given-names></name><name><surname>Nishimoto</surname><given-names>MS</given-names></name><name><surname>Bottrell</surname><given-names>CL</given-names></name><name><surname>Fineman</surname><given-names>LD</given-names></name><name><surname>Hamrick</surname><given-names>SE</given-names></name><name><surname>Glidden</surname><given-names>DV</given-names></name><etal/></person-group><article-title>Regional and central venous oxygen saturation monitoring
following pediatric cardiac surgery: concordance and association with
clinical variables</article-title><source>Pediatr Crit Care Med</source><year>2007</year><volume>8</volume><issue>2</issue><fpage>154</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">17273125</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>GM</given-names></name><name><surname>Brosig</surname><given-names>CL</given-names></name><name><surname>Mussatto</surname><given-names>KA</given-names></name><name><surname>Tweddell</surname><given-names>JS</given-names></name><name><surname>Ghanayem</surname><given-names>NS</given-names></name></person-group><article-title>Perioperative cerebral oxygen saturation in neonates with
hypoplastic left heart syndrome and childhood neurodevelopmental
outcome</article-title><source>J Thorac Cardiovasc Surg</source><year>2013</year><volume>146</volume><issue>5</issue><fpage>1153</fpage><lpage>1164</lpage><pub-id pub-id-type="pmid">23317941</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Hermandez</surname><given-names>JA</given-names></name><name><surname>Aldemira-Liz</surname><given-names>A</given-names></name><name><surname>Martinez-Lopez</surname><given-names>AI</given-names></name><name><surname>Cayuela</surname><given-names>A</given-names></name><name><surname>Charlo-Molina</surname><given-names>MT</given-names></name><name><surname>Cano-Franco</surname><given-names>J</given-names></name><etal/></person-group><article-title>Saturaci&#x000f3;n cerebral de oxigeno como marcador
hemodi&#x000e1;mico em la cirurgia card&#x000ed;aca</article-title><source>An Pediatr</source><year>2013</year><volume>79</volume><issue>4</issue><fpage>224</fpage><lpage>229</lpage></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klamt</surname><given-names>JG</given-names></name><name><surname>Nabarro</surname><given-names>PRT</given-names></name><name><surname>Vicente</surname><given-names>WVA</given-names></name><name><surname>Garcia</surname><given-names>LV</given-names></name><name><surname>Ferreira</surname><given-names>CA</given-names></name></person-group><article-title>Correla&#x000e7;&#x000e3;o entre a SvO2 e SjO2 durante a cirurgia
card&#x000ed;aca com circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea em
crian&#x000e7;as</article-title><source>Rev Bras Cir Cardiovasc</source><year>2011</year><volume>26</volume><issue>4</issue><fpage>597</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">22358275</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin 3rd</surname><given-names>EH</given-names></name><name><surname>Edmonds Jr</surname><given-names>HL</given-names></name><name><surname>Auden</surname><given-names>SM</given-names></name><name><surname>Seremet</surname><given-names>V</given-names></name><name><surname>Niznik</surname><given-names>G</given-names></name><name><surname>Sehic</surname><given-names>A</given-names></name><etal/></person-group><article-title>Benefit of neurophysiologic monitoring for pediatric cardiac
surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>1997</year><volume>114</volume><issue>5</issue><fpage>707</fpage><lpage>715</lpage><pub-id pub-id-type="pmid">9375600</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naguib</surname><given-names>AN</given-names></name><name><surname>Winch</surname><given-names>PD</given-names></name><name><surname>Sebastian</surname><given-names>R</given-names></name><name><surname>Gomez</surname><given-names>D</given-names></name><name><surname>Guzman</surname><given-names>L</given-names></name><name><surname>Rice</surname><given-names>J</given-names></name><etal/></person-group><article-title>The correlation of two cerebral saturation monitors with jugular
bulb oxygen saturation in children undergoing cardiopulmonary bypass for
congenital heart surgery</article-title><source>J Intensive Care Med</source><year>2016</year><volume>15</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul-Khaliq</surname><given-names>H</given-names></name><name><surname>Troitzsch</surname><given-names>D</given-names></name><name><surname>Berger</surname><given-names>F</given-names></name><name><surname>Lange</surname><given-names>PE</given-names></name></person-group><article-title>Regional transcranial oximetry with near infrared spectroscopy
(NIRS) in comparison with measuring oxygen saturation in the jugular bulb in
infants and children for monitoring cerebral oxygenation</article-title><source>Biomed Tech. (Berl)</source><year>2000</year><volume>45</volume><issue>11</issue><fpage>328</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">11155535</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurth</surname><given-names>CD</given-names></name><name><surname>McCann</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Miles</surname><given-names>I</given-names></name><name><surname>Loepke</surname><given-names>AW</given-names></name></person-group><article-title>Cerebral oxygen saturation-time threshold for hypoxic-ischemic
injury in piglets</article-title><source>Anesth Analg</source><year>2009</year><volume>108</volume><issue>4</issue><fpage>1268</fpage><lpage>1277</lpage><pub-id pub-id-type="pmid">19299799</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>G</given-names></name><name><surname>Rodichok</surname><given-names>LD</given-names></name><name><surname>Baylen</surname><given-names>BG</given-names></name><name><surname>Myers</surname><given-names>JL</given-names></name></person-group><article-title>EEG changes during open heart surgery on infants aged 6 months on
less: relationship to early neurologic morbidity</article-title><source>Pediatr Neurol</source><year>1994</year><volume>10</volume><issue>2</issue><fpage>124</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">8024660</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andropoulos</surname><given-names>DB</given-names></name><name><surname>Mizrahi</surname><given-names>EM</given-names></name><name><surname>Hrachorry</surname><given-names>RA</given-names></name><name><surname>Stayer</surname><given-names>SA</given-names></name><name><surname>Stark</surname><given-names>AR</given-names></name><name><surname>Heinle</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Electroencephalographic seizures after neonatal cardiac surgery
with high-flow cardiopulmonary bypass</article-title><source>Anesth Analg</source><year>2012</year><volume>110</volume><issue>6</issue><fpage>1680</fpage><lpage>1685</lpage></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>GD</given-names></name><name><surname>Ramamoorth</surname><given-names>C</given-names></name></person-group><article-title>Brain monitoring and protection during pediatric cardiac
surgery</article-title><source>Semin Cardiothorac Vasc Anesth</source><year>2007</year><volume>11</volume><issue>1</issue><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">17484171</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyama</surname><given-names>S</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>Y</given-names></name></person-group><article-title>Cerebral hypoperfusion during pediatric cardiac surgery detected
by combined bispectral index monitoring and transcranial Doppler
ultrasonography</article-title><source>J Clin Anesth</source><year>2011</year><volume>23</volume><issue>6</issue><fpage>498</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">21911197</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashida</surname><given-names>M</given-names></name><name><surname>Kin</surname><given-names>N</given-names></name><name><surname>Tomioka</surname><given-names>T</given-names></name><name><surname>Orii</surname><given-names>R</given-names></name><name><surname>Sekiyama</surname><given-names>H</given-names></name><name><surname>Usui</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cerebral ischemia during cardiac surgery in children detected by
combine monitoring of BIS and near-infrared spectroscopy</article-title><source>Br J Anaesth</source><year>2004</year><volume>92</volume><issue>5</issue><fpage>662</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">15033888</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stammet</surname><given-names>P</given-names></name><name><surname>Werer</surname><given-names>C</given-names></name><name><surname>Mertens</surname><given-names>L</given-names></name><name><surname>Lorang</surname><given-names>C</given-names></name><name><surname>Hemmer</surname><given-names>M</given-names></name></person-group><article-title>Bispectral index (BIS) helps predicting bad neurologic outcome in
comatome survivors after cardiac arrest and induced therapeutic
hypothermia</article-title><source>Resuscitation</source><year>2009</year><volume>80</volume><issue>4</issue><fpage>437</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">19217198</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andropoulos</surname><given-names>DB</given-names></name><name><surname>Brady</surname><given-names>K</given-names></name><name><surname>Easley</surname><given-names>RB</given-names></name><name><surname>Dickerson</surname><given-names>HA</given-names></name><name><surname>Voigt</surname><given-names>RG</given-names></name><name><surname>Shekerdemian</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Erythropoietin neuroprotection in neonatal cardiac surgery: a
phase I/II safety and efficacy trial</article-title><source>J Thorac Cardiovasc Surg</source><year>2013</year><volume>146</volume><issue>1</issue><fpage>124</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">23102686</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>EE</given-names></name><name><surname>Bonifacio</surname><given-names>SL</given-names></name><name><surname>Glass</surname><given-names>HC</given-names></name><name><surname>Juul</surname><given-names>SE</given-names></name><name><surname>Chang</surname><given-names>T</given-names></name><name><surname>Mayock</surname><given-names>DE</given-names></name><etal/></person-group><article-title>Erythropoietin and hypothermia for hypoxic-ischemic
encephalopathy</article-title><source>Pediatr Neurol</source><year>2014</year><volume>51</volume><issue>5</issue><fpage>657</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">25439577</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andropoulos</surname><given-names>DB</given-names></name><name><surname>Ahmad</surname><given-names>HB</given-names></name><name><surname>Haq</surname><given-names>T</given-names></name><name><surname>Brady</surname><given-names>K</given-names></name><name><surname>Stayer</surname><given-names>SA</given-names></name><name><surname>Meador</surname><given-names>MR</given-names></name><etal/></person-group><article-title>The association between brain injury, perioperative anesthetic
exposure, and 12-month neurodevelopmental outcomes after neonatal cardiac
surgery: a retrospective cohort study</article-title><source>Paediatr Anaesth</source><year>2014</year><volume>24</volume><issue>3</issue><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">24467569</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>RD</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Maze</surname><given-names>MD</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name></person-group><article-title>Dexmedetomidine provides cortical neuroprotection: impact on
anaesthetic-induced neuroapoptosis in the rat developing
brain</article-title><source>Acta Anaesthesiol Scand</source><year>2010</year><volume>54</volume><issue>6</issue><fpage>710</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">20003127</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klamt</surname><given-names>JG</given-names></name><name><surname>Vicente</surname><given-names>WVA</given-names></name><name><surname>Garcia</surname><given-names>LV</given-names></name><name><surname>Ferreira</surname><given-names>CA</given-names></name></person-group><article-title>Effects of dexmedetomidinefentanyl infusion on blood pressure and
heart rate during cardiac surgery in children</article-title><source>Anesthesiol Res Pract</source><year>2010</year><volume>2</volume><fpage>5</fpage><lpage>7</lpage></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobias</surname><given-names>JD</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Naguib</surname><given-names>A</given-names></name><name><surname>Yates</surname><given-names>AR</given-names></name></person-group><article-title>Dexmedetomidine: applications for the pediatric patient with
congenital heart disease</article-title><source>Pediatr Cardiol</source><year>2011</year><volume>32</volume><issue>8</issue><fpage>1075</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">21909772</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Dexmedetomidine: a review of applications for cardiac surgery
during perioperative period</article-title><source>J Anesth</source><year>2015</year><volume>29</volume><issue>1</issue><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">24913070</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>An</surname><given-names>R</given-names></name></person-group><article-title>Effects and safety of magnesium sulfate on neuroprotection: a
meta-analysis based PRISMA Guidelines</article-title><source>Medicine</source><year>2016</year><volume>95</volume><issue>1</issue><elocation-id>e2451</elocation-id><pub-id pub-id-type="pmid">26735551</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constantine</surname><given-names>MG</given-names></name><name><surname>Weiner</surname><given-names>SJ</given-names></name><collab>Eunice Kennedy Shriver National Institute of Child Health</collab><collab>Human Development Maternal-Fetal Medicine Units Network</collab></person-group><article-title>Effects of antenatal exposure to magnesium sulfate and
neuroprotection and mortality in preterm infants: a
meta-analysis</article-title><source>Obstet Gynecol</source><year>2009</year><volume>114</volume><issue>2</issue><issue-part>1</issue-part><fpage>354</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">19622997</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herroeder</surname><given-names>S</given-names></name><name><surname>Sch&#x000f6;nherr</surname><given-names>ME</given-names></name><name><surname>De Hert</surname><given-names>SG</given-names></name><name><surname>Hollmann</surname><given-names>MW</given-names></name></person-group><article-title>Magnesium: essentials for anesthesiologists</article-title><source>Anesthesiology</source><year>2011</year><volume>114</volume><issue>4</issue><fpage>971</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">21364460</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Meng</surname><given-names>M</given-names></name></person-group><article-title>The effect of lidocaine on early postoperative cognitive
dysfunction after coronary artery bypass surgery</article-title><source>Anesth Analg</source><year>2002</year><volume>95</volume><issue>5</issue><fpage>1134</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">12401580</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canavero</surname><given-names>S</given-names></name><name><surname>Bonicalzi</surname><given-names>V</given-names></name><name><surname>Narcisi</surname><given-names>P</given-names></name></person-group><article-title>Safety of magnesium-lidocaine combination for severe head injury:
the Turin lidomag pilot study</article-title><source>Surg Neurol</source><year>2003</year><volume>60</volume><issue>2</issue><fpage>165</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">12900133</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popp</surname><given-names>SS</given-names></name><name><surname>Lei</surname><given-names>B</given-names></name><name><surname>Kelemen</surname><given-names>E</given-names></name><name><surname>Fenton</surname><given-names>AA</given-names></name><name><surname>Cottrell</surname><given-names>JE</given-names></name><name><surname>Kass</surname><given-names>IS</given-names></name></person-group><article-title>Intravenous antiarrhythmic doses of lidocaine increase the
survival rate of CA1 neurons and improve cognitive outcome after transient
global cerebral ischemia in rats</article-title><source>Neuroscience</source><year>2011</year><volume>192</volume><fpage>537</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">21777661</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H-J</given-names></name><name><surname>Zhang</surname><given-names>Y-J</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>M-Y</given-names></name><name><surname>Xue</surname><given-names>M-Q</given-names></name><etal/></person-group><article-title>Chlorpromazine confers neuroprotection against brain ischemia by
activating BKca channel</article-title><source>Eur J Pharmacol</source><year>2014</year><volume>735</volume><fpage>38</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">24755143</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>J</given-names></name><name><surname>Ishida</surname><given-names>K</given-names></name></person-group><article-title>Neuroprotection after major cardiovascular
surgery</article-title><source>Curr Treat Options Neurol</source><year>2015</year><volume>17</volume><issue>7</issue><fpage>357</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">25975818</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>JP</given-names></name><name><surname>Mackensen</surname><given-names>GB</given-names></name><name><surname>Phillips-Bute</surname><given-names>B</given-names></name><name><surname>Grocott</surname><given-names>HP</given-names></name><name><surname>Glower</surname><given-names>DD</given-names></name><name><surname>Laskowitz</surname><given-names>DT</given-names></name><etal/></person-group><article-title>Randomized, double-blinded, placebo controlled study of
neuroprotection with lidocaine in cardiac surgery</article-title><source>Stroke</source><year>2009</year><volume>40</volume><issue>3</issue><fpage>880</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">19164788</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilotta</surname><given-names>F</given-names></name><name><surname>Gelb</surname><given-names>AW</given-names></name><name><surname>Stazi</surname><given-names>E</given-names></name><name><surname>Titi</surname><given-names>L</given-names></name><name><surname>Paolini</surname><given-names>FP</given-names></name><name><surname>Rosa</surname><given-names>G</given-names></name></person-group><article-title>Pharmacological perioperative brain neuroprotection: a
qualitative review of randomized clinical trials</article-title><source>Br J Anaesth</source><year>2013</year><volume>110</volume><issue>suppl 1</issue><fpage>i113</fpage><lpage>i120</lpage><pub-id pub-id-type="pmid">23562933</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chrysostomou</surname><given-names>C</given-names></name><name><surname>Sanchez-de-Toledo</surname><given-names>J</given-names></name><name><surname>Wearden</surname><given-names>P</given-names></name><name><surname>Jooste</surname><given-names>EH</given-names></name><name><surname>Lichtenstein</surname><given-names>SE</given-names></name><name><surname>Callahan</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Perioperative use of dexmedetomidine is associated with decreased
incidence of ventricular and supraventricular tachyarrhythmias after
congenital cardiac operations</article-title><source>Ann Thorac Surg</source><year>2011</year><volume>92</volume><issue>3</issue><fpage>964</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">21871284</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imoto</surname><given-names>Y</given-names></name><name><surname>Kado</surname><given-names>H</given-names></name><name><surname>Masuda</surname><given-names>M</given-names></name><name><surname>Yasui</surname><given-names>H</given-names></name></person-group><article-title>Effects of chlorpromazine as a systemic vasodilator during
cardiopulmonary bypass in neonates</article-title><source>Jpn J Thorac Cardiovasc Surg</source><year>2002</year><volume>50</volume><issue>6</issue><fpage>241</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">12073600</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>KI</given-names></name><name><surname>Delivoria-Papadopoulos</surname><given-names>M</given-names></name></person-group><article-title>Mechanisms of injury to newborn brain</article-title><source>Clin Perinatol</source><year>2006</year><volume>33</volume><issue>3</issue><fpage>573</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">16950312</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakan</surname><given-names>M</given-names></name><name><surname>Umutoglu</surname><given-names>T</given-names></name><name><surname>Topuz</surname><given-names>U</given-names></name><name><surname>Uysal</surname><given-names>H</given-names></name><name><surname>Bayram</surname><given-names>M</given-names></name><name><surname>Kadioglu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Opioid-free total intravenous anesthesia with propofol,
dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a
prospective, randomized, double-blinded study</article-title><source>Rev Bras Anestesiol</source><year>2015</year><volume>65</volume><issue>3</issue><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">25990496</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>JC</given-names></name><name><surname>Jacobs</surname><given-names>ML</given-names></name><name><surname>Andropoulus</surname><given-names>D</given-names></name><name><surname>Austin</surname><given-names>EH</given-names></name><name><surname>Jacobs</surname><given-names>JP</given-names></name><name><surname>Licht</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Protecting the infant brain during cardiac surgery: a systematic
review</article-title><source>Ann Thorac Surg</source><year>2012</year><volume>94</volume><issue>4</issue><fpage>1365</fpage><lpage>1373</lpage><pub-id pub-id-type="pmid">23006704</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>SP</given-names></name></person-group><article-title>Neurodevelopmental implications of the general anesthesia in
neonate and infants</article-title><source>Exp Neurol</source><year>2015</year><volume>272</volume><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">25862287</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name></person-group><article-title>Dual effects of ketamine neurotoxicity versus neuroprotection in
anesthesia for the developing brain</article-title><source>J Neurosurg Anesthesiol</source><year>2014</year><volume>26</volume><issue>2</issue><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">24275940</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>LK</given-names></name><name><surname>Gaynor</surname><given-names>JW</given-names></name><name><surname>Koh</surname><given-names>SJ</given-names></name><name><surname>Ittenbach</surname><given-names>RF</given-names></name><name><surname>Gerdes</surname><given-names>M</given-names></name><name><surname>Bernbaun</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Increasing cumulative exposure to volatile anesthetic agents is
associated with poorer neurodevelopmental outcomes in children with
hypoplastic left heart syndrome</article-title><source>J Thorac Cardiovasc Surg</source><year>2016</year><volume>152</volume><issue>2</issue><fpage>482</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">27183886</pub-id></element-citation></ref></ref-list></back></article>